TYSABRI Adverse Event: Lung neoplasm malignant
TYSABRI Adverse Event: Lung neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TYSABRI; Product category: Drug; Primary reaction: Lung neoplasm malignant.
| Primary drug | TYSABRI |
|---|---|
| Product category | Drug |
| Primary reaction | Lung neoplasm malignant |
| All reactions | Lung neoplasm malignant; Pneumonia |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Male |
| All drugs reported | TYSABRI; TYSABRI; TYSABRI |
| Reporter country | US |
| Reporter type | 3 |
| Report date | 20140313 |
| Report ID | 10005508 |
$299/mo
Try FDATracker →